Tevogen Bio Shares 2024 Financing Activity on One Year Anniversary of Becoming a Publicly Listed Company; Highlights Operational Efficiency
Provided By GlobeNewswire
Last update: Feb 14, 2025
WARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech company, shares a summary of the Company’s 2024 financing activity at the one year anniversary of being listed on the Nasdaq exchange.
Read more at globenewswire.comNASDAQ:TVGNW (3/7/2025, 8:00:01 PM)
0.0669
0 (-4.29%)
1.14
+0.04 (+3.64%)
Find more stocks in the Stock Screener
TVGNW Latest News and Analysis
3 days ago - ChartmillLet's have a look at the top gainers and losers one hour before the close of the markets of today's session.Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.
3 days ago - ChartmillFriday's pre-market session: top gainers and losersDiscover the top movers in Friday's pre-market session and stay informed about market dynamics.
